VIMTALABS Intraday Analysis...

VIMTALABS Share Price

Open 134.70 Change Price %
High 136.00 1 Day 0.00 0.00
Low 132.00 1 Week 1.80 1.38
Close 132.15 1 Month 4.55 3.57
Volume 24488 1 Year 38.85 41.64
52 Week High 164.30
52 Week Low 91.00
VIMTALABS Important Levels
Resistance 2 135.86
Resistance 1 134.33
Pivot 133.38
Support 1 129.97
Support 2 128.44
NSE INDIA Most Active Stocks
JPASSOCIAT 18.75 -2.60%
RCOM 13.60 -2.51%
BHEL 92.85 4.74%
HDIL 61.55 0.24%
PRAJIND 105.95 19.99%
SUZLON 13.60 -0.37%
JAICORPLTD 161.05 1.77%
IDEA 96.10 -2.39%
IBREALEST 212.50 -0.26%
PNB 186.50 -1.43%
More..
NSE INDIA Top Gainers Stocks
PRAJIND 105.95 19.99%
MTEDUCARE 68.60 19.93%
APTECHT 395.85 19.45%
PRECOT 101.95 19.03%
SPECIALITY 167.00 17.11%
RAJRAYON 0.35 16.67%
NAGREEKEXP 51.55 16.63%
DIAPOWER 18.45 15.67%
PITTILAM 78.35 15.39%
SIS 1032.15 14.63%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.15 -25.00%
LCCINFOTEC 0.35 -12.50%
NEULANDLAB 1133.60 -10.75%
PATSPINLTD 32.60 -9.94%
PANORAMUNI 9.35 -9.22%
COMPINFO 26.25 -7.89%
RUCHISOYA 24.75 -6.25%
QUESS 858.00 -6.17%
GLOBALVECT 184.15 -6.02%
LITL 0.80 -5.88%
More..

Vimta Labs Limited (NSE: VIMTALABS)

VIMTALABS Technical Analysis 3
As on 23rd Nov 2017 VIMTALABS Share Price closed @ 132.15 and we RECOMMEND Buy for LONG-TERM with Stoploss of 123.97 & Buy for SHORT-TERM with Stoploss of 131.23 we also expect STOCK to react on Following IMPORTANT LEVELS.
VIMTALABS Target for November
1st Target up-side 138.26
2nd Target up-side 143.62
3rd Target up-side 148.99
1st Target down-side 122.94
2nd Target down-side 117.58
3rd Target down-side 112.21
VIMTALABS Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 51.61 Sideways
MFI (14) MFI is 31.40 Sideways
CCI (20) CCI is 34.76 Sideways
WILLIAM %R (14) William %R is -64.65 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 127.34
10 Day Avg Volume Traded 19.76 % More then 10 Day Average Volume
VIMTALABS Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.vimta.com
VIMTALABS Address
VIMTALABS
Plot Nos.: 142/2 and 142
IDA Phase II
Hyderabad, 500051
India
Phone: 91 40 2726 4141
Fax: 91 40 2726 3657
VIMTALABS Latest News
Clarification sought from Vimta Labs Ltd   Hindu Business Line   - 18th Mar 15
Vimta Labs surges 20% on heavy volumes   Business Standard   - 13th Mar 15
Vimta Labs Ltd gets favorable verdict on service tax disputes   Equity Bulls   - 23rd Oct 14
CRISIL ratings for Indian debt instruments-Aug 12   Reuters   - 12th Aug 14
Buy Vimta Labs, Wockhardt, Allahabad Bank: Manav Chopra   Moneycontrol.com   - 07th Jul 14
Vimta Labs fails to execute Rs 30 cr projects   Business Standard   - 19th Sep 12
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading ...   Hindu Business Line   - 09th Apr 12
Vimta Labs standalone Dec '14 sales at Rs 25.15 crore   Moneycontrol.com   - 29th Mar 12
European firm seen circling Vimta Labs   Daily News & Analysis   - 04th Jun 11
Vimta Labs Board to consider Dividend for 2009-10   Equity Bulls   - 25th Apr 10
Interactive Technical Analysis Chart Vimta Labs Limited ( VIMTALABS NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Vimta Labs Limited
VIMTALABS Business Profile
Vimta Labs Limited provides contract research and testing services primarily in India. It offers analytical testing services for food and agriculture products, and drugs and pharmaceuticals, as well as tests water samples for various purposes and specifications. The company also provides environmental assessment services, including site selection and liability studies; environmental impact assessments; environment management plans; carrying capacity based regional studies; environmental audits; solid and hazardous waste management; risk assessments and disaster management plans; occupational health and safety, industrial hygiene; environmental baseline monitoring for air, meteorology, water, soil, noise, ecology, socio-economic, demography, etc.; industrial emission source monitoring; offshore sampling and analysis of marine water and sediments; marine ecological studies; marine impact assessment; rehabilitation and resettlement studies; forestry and ecological studies; geo-technical studies; geological and hydro-geological studies; land use/ land cover studies based on remote sensing; socio-economic studies; due diligence studies; epidemiological studies; wasteland management studies; and study on bio-indicators, as well as offers various other services under environment chemistry. In addition, it provides clinical research services, including Phase-I/ bioequivalence studies, as well as screening and recruitment services; and conducts studies on arious dosage forms, such as tablets, capsules, extended release preparations, gels, jellies, transdermal patches, injectibles, etc. Further, the company offers clinical reference lab services; pre-clinical services, including drug discovery services to pharmaceutical and biotech companies in the areas of pharmacology, DMPK/ADME, toxicology, and bioanalytical; and services in the area of cell and molecular biology. Vimta Labs Limited was founded in 1984 and is based in Hyderabad, India.